Department of Neurosurgery, University of Virginia Medical Center, Charlottesville, VA 22908, USA.
Spine (Phila Pa 1976). 2011 Sep 15;36(20):1685-91. doi: 10.1097/BRS.0b013e318216d825.
Retrospective review of a multi-institutional, multisurgeon database.
Assess for associations between bone morphogenetic protein (BMP) use and rate of complications in spinal fusion.
BMP is commonly used in spinal surgery to augment fusion; however, there is limited evidence demonstrating its associated complications.
We performed a retrospective analysis of all fusion cases submitted by members of the Scoliosis Research Society from 2004 to 2007. We stratified on the basis of the use of BMP and evaluated for complications and associated characteristics.
A total of 55,862 cases of spinal fusion were identified with BMP used in 21% (11,933) of the cases. Excluding anterior cervical fusions, there were no significant differences between fusions with and without BMP with regard to overall complications (8.4% vs. 8.5%; P = 0.5), wound infections (2.4% vs. 2.4%; P = 0.8), or epidural hematomas/seromas (0.2% vs. 0.2%; P = 0.3). Anterior cervical fusions with BMP were associated with more overall complications (5.8% vs. 2.4%; P < 0.001) and more wound infections (2.1% vs. 0.4%; P < 0.001) than fusions without BMP. On multivariate analysis for thoracolumbar and posterior cervical fusions, BMP use was not a significant predictor of complications (P = 0.334; odds ratio = 1.039; 95% confidence interval = 0.961-1.124; covariates were BMP use, patient age, revision vs. primary surgery). Multivariate analysis for anterior cervical spinal fusion demonstrated that BMP use remained a significant predictor of complications (P < 0.001, odds ratio = 1.6; 95% confidence interval = 1.516-1.721), after adjusting for the effects of patient age and whether the surgery was a revision procedure.
BMP use with anterior cervical fusion was associated with an increased incidence of complications. Use of BMP was not associated with more complications in thoracolumbar and posterior cervical fusions.
回顾性分析多机构多外科医生数据库。
评估骨形态发生蛋白(BMP)在脊柱融合中的使用与并发症发生率之间的关系。
BMP 常用于脊柱手术以增强融合;然而,证明其相关并发症的证据有限。
我们对 2004 年至 2007 年 Scoliosis Research Society 成员提交的所有融合病例进行了回顾性分析。我们根据 BMP 的使用情况进行分层,并评估并发症及其相关特征。
共确定 55862 例脊柱融合病例,其中 21%(11933 例)病例使用 BMP。排除前路颈椎融合术后,BMP 组和无 BMP 组在总体并发症(8.4%比 8.5%;P=0.5)、伤口感染(2.4%比 2.4%;P=0.8)或硬膜外血肿/血清肿(0.2%比 0.2%;P=0.3)方面无显著差异。前路颈椎融合术后 BMP 与更多的总体并发症(5.8%比 2.4%;P<0.001)和更多的伤口感染(2.1%比 0.4%;P<0.001)相关。后路颈椎和胸腰椎融合的多变量分析显示,BMP 使用不是并发症的显著预测因素(P=0.334;比值比=1.039;95%置信区间=0.961-1.124;协变量为 BMP 使用、患者年龄、初次手术与翻修手术)。前路颈椎融合的多变量分析显示,在调整患者年龄和手术是否为翻修手术的影响后,BMP 使用仍然是并发症的显著预测因素(P<0.001,比值比=1.6;95%置信区间=1.516-1.721)。
前路颈椎融合术中使用 BMP 与并发症发生率增加相关。BMP 在胸腰椎和后路颈椎融合中与更多并发症无关。